In a significant development within the Central and Eastern European healthcare sector, Finland’s leading private healthcare provider, Mehiläinen Group, has acquired Romania’s Regina Maria healthcare network.
Mehiläinen group acquires Regina Maria healthcare network in landmark €1 billion deal

In a significant development within the Central and Eastern European healthcare sector, Finland's leading private healthcare provider, Mehiläinen Group, has acquired Romania's Regina Maria healthcare network.
The transaction, valued at approximately €1 billion, also includes Serbia’s MediGroup. This acquisition is pending regulatory approval and is anticipated to conclude by the end of the year.
Mehiläinen announced on April 1, 2025 that it has signed agreements to acquire Regina Maria, a leading healthcare company in Romania, and MediGroup, a leading healthcare company in Serbia.
Regina Maria has experienced substantial growth under Mid Europa Partners, expanding to encompass 8 hospitals, 53 polyclinics, and 28 imaging centers. Over €250 million has been invested in acquisitions and facility development.
Janne-Olli Järvenpää, CEO of Mehiläinen Group, expressed enthusiasm about the acquisition, stating that Regina Maria is among the fastest-growing private healthcare providers in Europe, renowned for its high-quality medical services and exceptional management team.
„This is a transaction involving multiple parties and several jurisdictions, with both international and several local partners. The collaboration has been smooth, and we wish to extend our warm gratitude to all parties,” says Mehiläinen’s General Counsel Sami Koski.
Fady Chreih, CEO of Regina Maria, highlighted the strategic importance of this partnership, emphasizing the potential to transform private healthcare across Europe through combined expertise and a shared vision.
Regina Maria offers extensive medical clinic and hospital services to over 2 million customers annually with approximately 11,000 professionals. In its sister company, MediGroup, healthcare services are provided with over 2,500 employees. The completion of the acquisitions requires regulatory approvals.
⚠ Disclaimer: Informațiile prezentate de Medic24 au scop educativ și/sau informativ. Ele nu înlocuiesc consultul medical. Diagnosticul și tratamentul pot fi stabilite doar de un medic.
Potrivit legislației, nu vom publica comentarii ce conțin denumirea comercială a unor medicamente, dispozitive medicale sau suplimente alimentare. De asemenea, respingem categoric comentariile cu limbaj necivilizat, opiniile care îndeamnă la ură, homofobie, rasism, sau cele care aduc atingere imaginii altor persoane.